2.4 GVHD prophylaxis
The prophylaxis for acute GVHD (aGVHD) was composed of cyclosporine,
mycophenolate mofetil (MMF), and short-term methotrexate (MTX). The
discontinuation time of MMF was different according to the
transplantation type: (1) MMF was withdrawn when (White blood cells,
WBCs ) engrafted in patients who received matched related
transplantation (MRD) within 30 days post-HSCT; and (2) MMF was
withdrawn on day 45 post-HSCT in patients who received mismatched
related/haploidentical transplantation.